Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) Short Interest Update

Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) was the recipient of a large growth in short interest during the month of July. As of July 31st, there was short interest totaling 224,453 shares, a growth of 90.8% from the July 15th total of 117,659 shares. Based on an average daily trading volume, of 613,487 shares, the short-interest ratio is presently 0.4 days. Approximately 0.0% of the company’s stock are sold short.

Analyst Upgrades and Downgrades

Separately, Kepler Capital Markets upgraded shares of Coloplast A/S to a “strong-buy” rating in a research note on Wednesday, May 20th. One analyst has rated the stock with a Strong Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Hold”.

Coloplast A/S Stock Performance

OTCMKTS CLPBY opened at $6.58 on Tuesday. The firm has a market capitalization of $14.83 billion, a P/E ratio of 47.00, a price-to-earnings-growth ratio of 2.12 and a beta of 0.13. The company has a current ratio of 1.75, a quick ratio of 1.09 and a debt-to-equity ratio of 1.66. The firm’s fifty day moving average price is $6.23 and its two-hundred day moving average price is $6.68. Coloplast A/S has a 1 year low of $5.64 and a 1 year high of $10.03.

Coloplast A/S Company Profile

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.